Anti-inflammatory and analgetic properties of d-2-(6'-methoxy-2'-naphthyl)-propionic acid (naproxen).
D000700:Analgesics / Q000627:therapeutic use*; D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006099:Granuloma / Q000188:drug therapy; D006614:Hindlimb; D006854:Hydrocortisone / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007928:Lethal Dose 50; D008528:Mefenamic Acid / Q000627:therapeutic use; D009281:Naphthalenes / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D010653:Phenylbutazone / Q000627:therapeutic use; D011422:Propionates / Q000627:therapeutic use*; D051381:Rats; D013035:Spasm / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009281:Naphthalenes; D011422:Propionates; D008528:Mefenamic Acid; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin